Facebook Twitter Instagram YouTube Linkedin Contact

X-linked Retinoschisis Research

September 21, 2018

X-linked retinoschisis natural history studies
We are enrolling qualified patients with x-linked retinoschisis in order to measure disease progression in a group of patients with this disease.

X-linked retinoschisis treatment trials
We are studying the safety and efficacy of a new drug treatment for patients ≥ 18 years of age with x-linked retinoschisis. The goal of this study is to reduce retinal splitting and visual loss

 

In order to be seen at the Retina Foundation of the Southwest, you must have a referral from your ophthalmologist.

If you have a question related to x-linked retinoschisis, please contact us at 214-363-3911.

 

❮ News Articles
Share on: Facebook Twitter Linkedin
X-linked Retinoschisis Research

Related Articles

Mark Pennesi, M.D., Ph.D., FARVO, Director of Ophthalmic Genetics, celebrates first year with the Retina Foundation Meet Sharon and Harold Hosack Phase III Treatment Trial for Stargardt Disease Enrolls First Patient Measuring the Release of A Therapeutic Drug in a Controlled Lab Setting Retina Foundation Completes $3.7M Capital Campaign
Mailicon
Get the Latest Updates

Sign up to receive emails from Retina Foundation that will keep you up-to-date on our research and events.

  • This field is for validation purposes and should be left unchanged.
Contact Us

Contact Us

  • This field is for validation purposes and should be left unchanged.
x

Please check all that apply:

How did you learn about the
Retina Foundation?

  • This field is for validation purposes and should be left unchanged.
  • Please check all that apply:
Contact Us

Request an Appointment

Please complete this form if you are interested in speaking to a member of our team about your AMD.

all fields required

DOWNLOAD Printable Form